Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer

Figure 4

Internal validation of the prognostic signature. (a–c) Kaplan–Meier survival analysis and the time-dependent ROC analysis of the risk score and gene cluster for predicting OS in the GSE62254 cohort. (d–f) Kaplan–Meier survival analysis and the time-dependent ROC analysis of the risk score and gene cluster for predicting OS in the GSE15459 cohort. (g–i) Kaplan–Meier survival analysis and the time-dependent ROC analysis of the risk score and gene cluster for predicting OS in the GSE26901 cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)